{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:11:58Z","timestamp":1762377118129},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,16]]},"DOI":"10.7759\/cureus.23226","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T18:52:56Z","timestamp":1647456776000},"source":"Crossref","is-referenced-by-count":2,"title":["Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis"],"prefix":"10.7759","author":[{"given":"Farrukh","family":"Munir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafiza Wajeeha","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Burhan Majeed","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Shaukat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08104.x","article-title":"The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis","volume":"150","author":"Andr\u00e8s E","year":"2010","unstructured":"Andr\u00e8s E, Maloisel F, Zimmer J. The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis. Br J Haematol. 2010, 150:3-8. 10.1111\/j.1365-2141.2010.08104.x","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn F","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007, 146:657-65. 10.7326\/0003-4819-146-9-200705010-00009","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2010.05.006","article-title":"Neutrophil kinetics in health and disease","volume":"31","author":"Summers C","year":"2010","unstructured":"Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER. Neutrophil kinetics in health and disease. Trends Immunol. 2010, 31:318-24. 10.1016\/j.it.2010.05.006","journal-title":"Trends Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2008.02950.x","article-title":"Neutrophil mobilization and clearance in the bone marrow","volume":"125","author":"Furze RC","year":"2008","unstructured":"Furze RC, Rankin SM. Neutrophil mobilization and clearance in the bone marrow. Immunology. 2008, 125:281-8. 10.1111\/j.1365-2567.2008.02950.x","journal-title":"Immunology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.2.449","article-title":"PECAM-1 is required for transendothelial migration of leukocytes","volume":"178","author":"Muller WA","year":"1993","unstructured":"Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med. 1993, 178:449-60. 10.1084\/jem.178.2.449","journal-title":"J Exp Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1006\/smim.2001.0344","article-title":"Selectins: critical mediators of leukocyte recruitment","volume":"14","author":"Patel KD","year":"2002","unstructured":"Patel KD, Cuvelier SL, Wiehler S. Selectins: critical mediators of leukocyte recruitment. Semin Immunol. 2002, 14:73-81. 10.1006\/smim.2001.0344","journal-title":"Semin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-133-12-3591","article-title":"Oxygen-dependent killing of Staphylococcus aureus by human neutrophils","volume":"133","author":"Edwards SW","year":"1987","unstructured":"Edwards SW, Say JE, Hart CA. Oxygen-dependent killing of Staphylococcus aureus by human neutrophils. J Gen Microbiol. 1987, 133:3591-7. 10.1099\/00221287-133-12-3591","journal-title":"J Gen Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-4887.1995.tb01503.x","article-title":"Neutropenia caused by copper deficiency: possible mechanisms of action","volume":"53","author":"Percival SS","year":"1995","unstructured":"Percival SS. Neutropenia caused by copper deficiency: possible mechanisms of action. Nutr Rev. 1995, 53:59-66. 10.1111\/j.1753-4887.1995.tb01503.x","journal-title":"Nutr Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/lc.1999.v133.a94931","article-title":"Benign ethnic neutropenia: what is a normal absolute neutrophil count?","volume":"133","author":"Haddy TB","year":"1999","unstructured":"Haddy TB, Rana SR, Castro O. Benign ethnic neutropenia: what is a normal absolute neutrophil count?. J Lab Clin Med. 1999, 133:15-22. 10.1053\/lc.1999.v133.a94931","journal-title":"J Lab Clin Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2221","article-title":"Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease","volume":"97","author":"Watanabe N","year":"2012","unstructured":"Watanabe N, Narimatsu H, Noh JY, et al.. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease. J Clin Endocrinol Metab. 2012, 97:E49-53. 10.1210\/jc.2011-2221","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq339","article-title":"Ceftriaxone-related agranulocytosis during outpatient parenteral antibiotic therapy","volume":"65","author":"Duncan CJ","year":"2010","unstructured":"Duncan CJ, Evans TJ, Seaton RA. Ceftriaxone-related agranulocytosis during outpatient parenteral antibiotic therapy. J Antimicrob Chemother. 2010, 65:2483-4. 10.1093\/jac\/dkq339","journal-title":"J Antimicrob Chemother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8652(199803)57:3<206::aid-ajh4>3.0.co;2-z","article-title":"Drug-associated agranulocytosis: 20 years of reporting in The Netherlands (1974-1994)","volume":"57","author":"van der Klauw MM","year":"1998","unstructured":"van der Klauw MM, Wilson JH, Stricker BH. Drug-associated agranulocytosis: 20 years of reporting in The Netherlands (1974-1994). Am J Hematol Oncol. 1998, 57:206-11. 10.1002\/(sici)1096-8652(199803)57:3&lt;206::aid-ajh4&gt;3.0.co;2-z","journal-title":"Am J Hematol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1592\/phco.20.5.484.35058","article-title":"Fluconazole-induced agranulocytosis with eosinophilia","volume":"20","author":"Wong-Beringer A","year":"2000","unstructured":"Wong-Beringer A, Shriner K. Fluconazole-induced agranulocytosis with eosinophilia. Pharmacotherapy. 2000, 20:484-6. 10.1592\/phco.20.5.484.35058","journal-title":"Pharmacotherapy"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2165\/00128415-201113690-00074","article-title":"Ganciclovir\/prednisolone infections and agranulocytosis: case report","volume":"1369","author":"Sakoda C","year":"2011","unstructured":"Sakoda C. Ganciclovir\/prednisolone infections and agranulocytosis: case report. Reactions. 2011, 1369:10.2165\/00128415-201113690-00074","journal-title":"Reactions"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-4-269","article-title":"Agranulocytosis and hepatic toxicity with ticlopidine therapy: a case report","volume":"4","author":"Previtera AM","year":"2010","unstructured":"Previtera AM, Pagani R. Agranulocytosis and hepatic toxicity with ticlopidine therapy: a case report. J Med Case Rep. 2010, 4:269. 10.1186\/1752-1947-4-269","journal-title":"J Med Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-014-1701-0","article-title":"Anticonvulsant drugs and hematological disease","volume":"35","author":"Verrotti A","year":"2014","unstructured":"Verrotti A, Scaparrotta A, Grosso S, Chiarelli F, Coppola G. Anticonvulsant drugs and hematological disease. Neurol Sci. 2014, 35:983-93. 10.1007\/s10072-014-1701-0","journal-title":"Neurol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1989.tb136698.x","article-title":"Agranulocytosis after ranitidine administration","volume":"150","author":"Lane GP","year":"1989","unstructured":"Lane GP, Speed B. Agranulocytosis after ranitidine administration. Med J Aust. 1989, 150:595-6. 10.5694\/j.1326-5377.1989.tb136698.x","journal-title":"Med J Aust"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0009-2797(02)00052-2","article-title":"Idiosyncratic NSAID drug induced oxidative stress","volume":"142","author":"Galati G","year":"2002","unstructured":"Galati G, Tafazoli S, Sabzevari O, Chan TS, O'Brien PJ. Idiosyncratic NSAID drug induced oxidative stress. Chem Biol Interact. 2002, 142:25-41. 10.1016\/s0009-2797(02)00052-2","journal-title":"Chem Biol Interact"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.8.1101","article-title":"Clozapine-induced agranulocytosis and its genetic determinants","volume":"9","author":"Opgen-Rhein C","year":"2008","unstructured":"Opgen-Rhein C, Dettling M. Clozapine-induced agranulocytosis and its genetic determinants. Pharmacogenomics. 2008, 9:1101-11. 10.2217\/14622416.9.8.1101","journal-title":"Pharmacogenomics"},{"key":"ref21","article-title":"The marketing of herbal supplements to an uninformed audience: should the FDA regulate pharmaceutical companies that produce supplements?","volume":"1","author":"Scott J","year":"2013","unstructured":"Scott J, Giovinazzo T, Sher A. The marketing of herbal supplements to an uninformed audience: should the FDA regulate pharmaceutical companies that produce supplements?. Adv Pharm Ethnomedicines. 2013, 1:4-6.","journal-title":"Adv Pharm Ethnomedicines"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e32834da9ef","article-title":"Agranulocytosis and other consequences due to use of illicit cocaine contaminated with levamisole","volume":"19","author":"Buchanan JA","year":"2012","unstructured":"Buchanan JA, Lavonas EJ. Agranulocytosis and other consequences due to use of illicit cocaine contaminated with levamisole. Curr Opin Hematol. 2012, 19:27-31. 10.1097\/MOH.0b013e32834da9ef","journal-title":"Curr Opin Hematol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20489","article-title":"Relative incidence of agranulocytosis and aplastic anemia","volume":"81","author":"Kaufman DW","year":"2006","unstructured":"Kaufman DW, Kelly JP, Issaragrisil S, et al.. Relative incidence of agranulocytosis and aplastic anemia. Am J Hematol. 2006, 81:65-7. 10.1002\/ajh.20489","journal-title":"Am J Hematol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/18-190","article-title":"Agranulocytosis from outpatient antimicrobial treatment with ceftriaxone: a case report","volume":"23","author":"Genchanok Y","year":"2019","unstructured":"Genchanok Y, Tolu SS, Wang H, Arora S. Agranulocytosis from outpatient antimicrobial treatment with ceftriaxone: a case report. Perm J. 2019, 23:10.7812\/TPP\/18-190","journal-title":"Perm J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08042.x","article-title":"Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes","volume":"79","author":"Juli\u00e1 A","year":"1991","unstructured":"Juli\u00e1 A, Olona M, Bueno J, et al.. Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes. Br J Haematol. 1991, 79:366-71. 10.1111\/j.1365-2141.1991.tb08042.x","journal-title":"Br J Haematol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4172\/2332-0877.1000191","article-title":"Drug-induced agranulocytosis in elderly patients: diagnosis and management of life-threatening infections and septic shock","volume":"2","author":"Andr\u00e8s E","year":"2014","unstructured":"Andr\u00e8s E, Mourot R, Keller O, Serraj K, Vogel T. Drug-induced agranulocytosis in elderly patients: diagnosis and management of life-threatening infections and septic shock. J Infect Dis Ther. 2014, 2:191. 10.4172\/2332-0877.1000191","journal-title":"J Infect Dis Ther"},{"key":"ref27","article-title":"Investigation of the Mechanisms of Drug-induced Agranulocytosis","author":"Ip JR","year":"2009","unstructured":"Ip JR. Investigation of the Mechanisms of Drug-induced Agranulocytosis. University of Toronto, Toronto; 2009."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2015.985649","article-title":"Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis","volume":"11","author":"Johnston A","year":"2015","unstructured":"Johnston A, Uetrecht J. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis. Expert Opin Drug Metab Toxicol. 2015, 11:243-57. 10.1517\/17425255.2015.985649","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5757","article-title":"Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles","volume":"5","author":"Goldstein JI","year":"2014","unstructured":"Goldstein JI, Jarskog LF, Hilliard C, et al.. Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles. Nat Commun. 2014, 5:1-9. 10.1038\/ncomms5757","journal-title":"Nat Commun"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/BF01476864","article-title":"HLA-B27, antinuclear antibodies and drug-induced agranulocytosis","volume":"56","author":"Schmidt KL","year":"1978","unstructured":"Schmidt KL, Mueller-Eckhardt C, Breithaupt H. HLA-B27, antinuclear antibodies and drug-induced agranulocytosis. Klin Wochenschr. 1978, 56:1189-91. 10.1007\/BF01476864","journal-title":"Klin Wochenschr"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/92.8.455","article-title":"Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections","volume":"92","author":"Sheng WH","year":"1999","unstructured":"Sheng WH, Hung CC, Chen YC, Fang CT, Hsieh SM, Chang SC, Hsieh WC. Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections. QJM. 1999, 92:455-61. 10.1093\/qjmed\/92.8.455","journal-title":"QJM"},{"key":"ref32","article-title":"Antithyroid drug-induced agranulocytosis: report of 13 cases","volume":"30","author":"Huang CH","year":"2007","unstructured":"Huang CH, Li KL, Wu JH, Wang PN, Juang JH. Antithyroid drug-induced agranulocytosis: report of 13 cases. Chang Gung Med J. 2007, 30:242-8.","journal-title":"Chang Gung Med J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2569","article-title":"Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan","volume":"98","author":"Nakamura H","year":"2013","unstructured":"Nakamura H, Miyauchi A, Miyawaki N, Imagawa J. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J Clin Endocrinol Metab. 2013, 98:4776-83. 10.1210\/jc.2013-2569","journal-title":"J Clin Endocrinol Metab"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1089\/105072504323150787","article-title":"Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis","volume":"14","author":"Tajiri J","year":"2004","unstructured":"Tajiri J, Noguchi S. Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis. Thyroid. 2004, 14:459-62. 10.1089\/105072504323150787","journal-title":"Thyroid"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.ej12-0332","article-title":"The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis","volume":"60","author":"Yang J","year":"2013","unstructured":"Yang J, Zhong J, Xiao XH, et al.. The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis. Endocr J. 2013, 60:185-9. 10.1507\/endocrj.ej12-0332","journal-title":"Endocr J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2005.20.4.335","article-title":"Management of a pregnant patient with Graves' disease complicated by propylthiouracil induced agranulocytosis","volume":"20","author":"Cho YY","year":"2005","unstructured":"Cho YY, Shon HS, Yoon HD. Management of a pregnant patient with Graves' disease complicated by propylthiouracil induced agranulocytosis. Korean J Intern Med. 2005, 20:335-8. 10.3904\/kjim.2005.20.4.335","journal-title":"Korean J Intern Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.11.12","article-title":"Clinical presentation and management of drug-induced agranulocytosis","volume":"4","author":"Andr\u00e8s E","year":"2011","unstructured":"Andr\u00e8s E, Zimmer J, Mecili M, Weitten T, Alt M, Maloisel F. Clinical presentation and management of drug-induced agranulocytosis. Expert Rev Hematol. 2011, 4:143-51. 10.1586\/ehm.11.12","journal-title":"Expert Rev Hematol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/s0953-6205(02)00085-7","article-title":"Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature","volume":"13","author":"Andr\u00e8s E","year":"2002","unstructured":"Andr\u00e8s E, Maloisel F, Kurtz J-E, et al.. Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature. Eur J Intern Med. 2002, 13:324-8. 10.1016\/s0953-6205(02)00085-7","journal-title":"Eur J Intern Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q467","article-title":"Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug reexposure","volume":"46","author":"Duff JM","year":"2012","unstructured":"Duff JM, Moreb JS, Muwalla F. Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug reexposure. Ann Pharmacother. 2012, 46:e1. 10.1345\/aph.1Q467","journal-title":"Ann Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/90555-ceftriaxone-induced-reversible-agranulocytosis-a-case-report-and-review-of-drug-induced-agranulocytosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:37Z","timestamp":1707507337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/90555-ceftriaxone-induced-reversible-agranulocytosis-a-case-report-and-review-of-drug-induced-agranulocytosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.23226","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}